no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A consolidated catalogue and graphical annotation of dbSNP polymorphisms in the human tissue kallikrein (KLK) locus
|
Goard, Carolyn A. |
|
2007 |
|
3 |
p. 303-312 10 p. |
article |
2 |
Activation of a pro-survival pathway IL-6/JAK2/STAT3 contributes to glial fibrillary acidic protein induction during the cholera toxin-induced differentiation of C6 malignant glioma cells
|
Shu, Minfeng |
|
2011 |
|
3 |
p. 265-272 8 p. |
article |
3 |
A DNA methylation-based definition of biologically distinct breast cancer subtypes
|
Stefansson, Olafur A. |
|
2015 |
|
3 |
p. 555-568 14 p. |
article |
4 |
Adseverin: A novel cisplatin-resistant marker in the human bladder cancer cell line HT1376 identified by quantitative proteomic analysis
|
Miura, Noriyoshi |
|
2012 |
|
3 |
p. 311-322 12 p. |
article |
5 |
ALDH+ tumor-initiating cells exhibiting gain in NOTCH1 gene copy number have enhanced regrowth sensitivity to a γ-secretase inhibitor and irinotecan in colorectal cancer
|
Arcaroli, John J. |
|
2012 |
|
3 |
p. 370-381 12 p. |
article |
6 |
Angiogenin interacts with the plasminogen activation system at the cell surface of breast cancer cells to regulate plasmin formation and cell migration
|
Dutta, Sujoy |
|
2014 |
|
3 |
p. 483-507 25 p. |
article |
7 |
An interview with Alexander Eggermont
|
Fricker, Janet |
|
2009 |
|
3 |
p. 188-191 4 p. |
article |
8 |
An oncolytic adenovirus regulated by a radiation-inducible promoter selectively mediates hSulf-1 gene expression and mutually reinforces antitumor activity of I131-metuximab in hepatocellular carcinoma
|
Zhang, Yan |
|
2013 |
|
3 |
p. 346-358 13 p. |
article |
9 |
Barriers to translation of research
|
Gannon, Frank |
|
2007 |
|
3 |
p. 244-245 2 p. |
article |
10 |
Biobanking for better healthcare
|
Riegman, Peter H.J. |
|
2008 |
|
3 |
p. 213-222 10 p. |
article |
11 |
Blood circulating tumor DNA for non-invasive genotyping of colon cancer patients
|
Siravegna, Giulia |
|
2016 |
|
3 |
p. 475-480 6 p. |
article |
12 |
Bone marrows from neuroblastoma patients: An excellent source for tumor genome analyses
|
Abbasi, M. Reza |
|
2015 |
|
3 |
p. 545-554 10 p. |
article |
13 |
BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation
|
Stordal, Britta |
|
2013 |
|
3 |
p. 567-579 13 p. |
article |
14 |
Cell-free circulating tumour DNA as a liquid biopsy in breast cancer
|
De Mattos-Arruda, Leticia |
|
2016 |
|
3 |
p. 464-474 11 p. |
article |
15 |
Challenges in circulating tumor cell detection by the CellSearch system
|
Andree, Kiki C. |
|
2016 |
|
3 |
p. 395-407 13 p. |
article |
16 |
Circulating free xeno-microRNAs – The new kids on the block
|
Fabris, Linda |
|
2016 |
|
3 |
p. 503-508 6 p. |
article |
17 |
Circulating tumor cells in breast cancer
|
Bidard, Francois-Clement |
|
2016 |
|
3 |
p. 418-430 13 p. |
article |
18 |
Circulating tumor cell technologies
|
Ferreira, Meghaan M. |
|
2016 |
|
3 |
p. 374-394 21 p. |
article |
19 |
Clinical and biological significance of circulating tumor cells in cancer
|
Masuda, Takaaki |
|
2016 |
|
3 |
p. 408-417 10 p. |
article |
20 |
Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer
|
Riva, Francesca |
|
2016 |
|
3 |
p. 481-493 13 p. |
article |
21 |
Conference calendar
|
|
|
2008 |
|
3 |
p. 282-284 3 p. |
article |
22 |
Conference calendar
|
|
|
2007 |
|
3 |
p. 356-358 3 p. |
article |
23 |
Conference calendar
|
|
|
2009 |
|
3 |
p. 269- 1 p. |
article |
24 |
Contents of Molecular Oncology Volume 2
|
|
|
2008 |
|
3 |
p. 285-287 3 p. |
article |
25 |
Contents of Molecular Oncology Volume 3
|
|
|
2009 |
|
3 |
p. 270-272 3 p. |
article |
26 |
Corrigendum to “Tracing the tumor lineage” [Mol. Oncol. 4 (2010) 267–283]
|
Navin, Nicholas E. |
|
2011 |
|
3 |
p. 302- 1 p. |
article |
27 |
CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas
|
Chen, Wangbing |
|
2014 |
|
3 |
p. 704-716 13 p. |
article |
28 |
Development and validation of a microRNA-based diagnostic assay for classification of renal cell carcinomas
|
Spector, Yael |
|
2013 |
|
3 |
p. 732-738 7 p. |
article |
29 |
Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma
|
Carlino, Matteo S. |
|
2014 |
|
3 |
p. 544-554 11 p. |
article |
30 |
Discovery of epitopes for targeting the human epidermal growth factor receptor 2 (HER2) with antibodies
|
Rockberg, Johan |
|
2009 |
|
3 |
p. 238-247 10 p. |
article |
31 |
DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivity
|
van Jaarsveld, Marijn T.M. |
|
2014 |
|
3 |
p. 458-468 11 p. |
article |
32 |
DNA polymerase β deficiency is linked to aggressive breast cancer: A comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts
|
Abdel-Fatah, Tarek M.A. |
|
2014 |
|
3 |
p. 520-532 13 p. |
article |
33 |
Dual inhibition of Janus and Src family kinases by novel indirubin derivative blocks constitutively-activated Stat3 signaling associated with apoptosis of human pancreatic cancer cells
|
Nam, Sangkil |
|
2013 |
|
3 |
p. 369-378 10 p. |
article |
34 |
Ectopic expression of plasma membrane targeted subunits of the Ndc80-complex as a tool to study kinetochore biochemistry
|
Holmström, Tim H. |
|
2009 |
|
3 |
p. 262-268 7 p. |
article |
35 |
Editorial Board
|
|
|
2015 |
|
3 |
p. ii- 1 p. |
article |
36 |
Editorial Board
|
|
|
2008 |
|
3 |
p. ii- 1 p. |
article |
37 |
Editorial Board
|
|
|
2007 |
|
3 |
p. ii- 1 p. |
article |
38 |
Editorial Board
|
|
|
2009 |
|
3 |
p. ii- 1 p. |
article |
39 |
Editorial Board
|
|
|
2010 |
|
3 |
p. ii- 1 p. |
article |
40 |
Editorial board
|
|
|
2014 |
|
3 |
p. ii- 1 p. |
article |
41 |
Editorial Board
|
|
|
2016 |
|
3 |
p. ii- 1 p. |
article |
42 |
Editorial Board
|
|
|
2013 |
|
3 |
p. ii- 1 p. |
article |
43 |
Editorial Board
|
|
|
2011 |
|
3 |
p. ii- 1 p. |
article |
44 |
Editorial Board
|
|
|
2012 |
|
3 |
p. ii- 1 p. |
article |
45 |
Effects of endoplasmic reticulum stressors on maturation and signaling of hemizygous and heterozygous wild-type and mutant forms of KIT
|
Brahimi-Adouane, Sabrina |
|
2013 |
|
3 |
p. 323-333 11 p. |
article |
46 |
EGFR and myosin II inhibitors cooperate to suppress EGFR-T790M-mutant NSCLC cells
|
Chiu, Huan-Chih |
|
2012 |
|
3 |
p. 299-310 12 p. |
article |
47 |
Endoplasmic reticulum stress and cell death in mTORC1-overactive cells is induced by nelfinavir and enhanced by chloroquine
|
Johnson, Charlotte E. |
|
2015 |
|
3 |
p. 675-688 14 p. |
article |
48 |
Estradiol–estrogen receptor: A key interplay of the expression of syndecan-2 and metalloproteinase-9 in breast cancer cells
|
Kousidou, Olga Ch. |
|
2008 |
|
3 |
p. 223-232 10 p. |
article |
49 |
Estrogen receptor-α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells
|
Li, Guangliang |
|
2013 |
|
3 |
p. 611-624 14 p. |
article |
50 |
EVI1 splice variants modulate functional responses in ovarian cancer cells
|
Dutta, Punashi |
|
2013 |
|
3 |
p. 647-668 22 p. |
article |
51 |
Exon 2 deletion splice variant of γ-glutamyl carboxylase causes des-γ-carboxy prothrombin production in hepatocellular carcinoma cell lines
|
Ueda, Naoki |
|
2008 |
|
3 |
p. 241-249 9 p. |
article |
52 |
FLT3 signals via the adapter protein Grb10 and overexpression of Grb10 leads to aberrant cell proliferation in acute myeloid leukemia
|
Kazi, Julhash U. |
|
2013 |
|
3 |
p. 402-418 17 p. |
article |
53 |
Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution
|
Zhou, Wenjing |
|
2009 |
|
3 |
p. 214-219 6 p. |
article |
54 |
Functional studies on circulating and disseminated tumor cells in carcinoma patients
|
Alix-Panabières, Catherine |
|
2016 |
|
3 |
p. 443-449 7 p. |
article |
55 |
Functional validation of putative tumor suppressor gene C13ORF18 in cervical cancer by Artificial Transcription Factors
|
Huisman, Christian |
|
2013 |
|
3 |
p. 669-679 11 p. |
article |
56 |
Gene expression profiling and DNA methylation analyses of CTCs
|
Lianidou, Evi S. |
|
2016 |
|
3 |
p. 431-442 12 p. |
article |
57 |
Genetic susceptibility to breast cancer
|
Mavaddat, Nasim |
|
2010 |
|
3 |
p. 174-191 18 p. |
article |
58 |
Genomic instability in breast cancer: Pathogenesis and clinical implications
|
Kwei, Kevin A. |
|
2010 |
|
3 |
p. 255-266 12 p. |
article |
59 |
Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2
|
Li, Likun |
|
2013 |
|
3 |
p. 484-496 13 p. |
article |
60 |
Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue
|
Aktas, Bilge |
|
2014 |
|
3 |
p. 717-727 11 p. |
article |
61 |
Has the US Cancer Centre model been ‘successful’? Lessons for the European cancer community
|
Sullivan, Richard |
|
2009 |
|
3 |
p. 192-203 12 p. |
article |
62 |
HDAC1-mSin3a-NCOR1, Dnmt3b-HDAC1-Egr1 and Dnmt1-PCNA-UHRF1-G9a regulate the NY-ESO1 gene expression
|
Cartron, Pierre-François |
|
2013 |
|
3 |
p. 452-463 12 p. |
article |
63 |
HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancer
|
Boulbes, Delphine R. |
|
2015 |
|
3 |
p. 586-600 15 p. |
article |
64 |
Heterogeneity among RIP-Tag2 insulinomas allows vascular endothelial growth factor-A independent tumor expansion as revealed by studies in Shb mutant mice: Implications for tumor angiogenesis
|
Åkerblom, Björn |
|
2012 |
|
3 |
p. 333-346 14 p. |
article |
65 |
High expression of microRNA-625-3p is associated with poor response to first-line oxaliplatin based treatment of metastatic colorectal cancer
|
Rasmussen, Mads H. |
|
2013 |
|
3 |
p. 637-646 10 p. |
article |
66 |
High tumor levels of IL6 and IL8 abrogate preclinical efficacy of the γ-secretase inhibitor, RO4929097
|
He, Wei |
|
2011 |
|
3 |
p. 292-301 10 p. |
article |
67 |
Histological types of breast cancer: How special are they?
|
Weigelt, Britta |
|
2010 |
|
3 |
p. 192-208 17 p. |
article |
68 |
Honokiol inhibits epithelial–mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis
|
Avtanski, Dimiter B. |
|
2014 |
|
3 |
p. 565-580 16 p. |
article |
69 |
Human papillomavirus (HPV)-18 E6 oncoprotein interferes with the epithelial cell polarity Par3 protein
|
Facciuto, Florencia |
|
2014 |
|
3 |
p. 533-543 11 p. |
article |
70 |
Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7
|
Lindquist, David |
|
2007 |
|
3 |
p. 350-355 6 p. |
article |
71 |
Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: Relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease
|
Celis, Julio E. |
|
2007 |
|
3 |
p. 321-349 29 p. |
article |
72 |
Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer
|
Bayani, Jane |
|
2008 |
|
3 |
p. 250-260 11 p. |
article |
73 |
Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling
|
Nam, Sangkil |
|
2012 |
|
3 |
p. 276-283 8 p. |
article |
74 |
Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins
|
Myhre, Simen |
|
2013 |
|
3 |
p. 704-718 15 p. |
article |
75 |
Infrastructure for translational research in Asia
|
Harris Cheng, Margaret |
|
2007 |
|
3 |
p. 255-257 3 p. |
article |
76 |
Inhibition of NEDD8-conjugation pathway by novel molecules: Potential approaches to anticancer therapy
|
Tanaka, Tomoaki |
|
2012 |
|
3 |
p. 267-275 9 p. |
article |
77 |
Inside the European Science Foundation
|
Fricker, Janet |
|
2008 |
|
3 |
p. 197-199 3 p. |
article |
78 |
Is metastasis predetermined?
|
Weinberg, Robert A. |
|
2007 |
|
3 |
p. 263-264 2 p. |
article |
79 |
KLF4 overexpression and apigenin treatment down regulated anti-apoptotic Bcl-2 proteins and matrix metalloproteinases to control growth of human malignant neuroblastoma SK-N-DZ and IMR-32 cells
|
Mohan, Nishant |
|
2013 |
|
3 |
p. 464-474 11 p. |
article |
80 |
Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells
|
Giordano, Cinzia |
|
2013 |
|
3 |
p. 379-391 13 p. |
article |
81 |
Lipoplex mediated silencing of membrane regulators (CD46, CD55 and CD59) enhances complement-dependent anti-tumor activity of trastuzumab and pertuzumab
|
Mamidi, Srinivas |
|
2013 |
|
3 |
p. 580-594 15 p. |
article |
82 |
Liquid biopsy: Potential and challenges
|
Pantel, Klaus |
|
2016 |
|
3 |
p. 371-373 3 p. |
article |
83 |
Liquid biopsy utility for the surveillance of cutaneous malignant melanoma patients
|
Huang, Sharon K. |
|
2016 |
|
3 |
p. 450-463 14 p. |
article |
84 |
Looking back, to go forward
|
Moreira, José M.A. |
|
2014 |
|
3 |
p. 445-446 2 p. |
article |
85 |
Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy
|
Moestue, Siver Andreas |
|
2011 |
|
3 |
p. 224-241 18 p. |
article |
86 |
Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer
|
Wei, Siwei |
|
2013 |
|
3 |
p. 297-307 11 p. |
article |
87 |
Micro-RNAs and breast cancer
|
Le Quesne, John |
|
2010 |
|
3 |
p. 230-241 12 p. |
article |
88 |
MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein
|
Yao, Yilong |
|
2015 |
|
3 |
p. 640-656 17 p. |
article |
89 |
miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2
|
Kronski, Emanuel |
|
2014 |
|
3 |
p. 581-595 15 p. |
article |
90 |
miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization
|
Valencia, Karmele |
|
2014 |
|
3 |
p. 689-703 15 p. |
article |
91 |
miRNA expression profiling of mycosis fungoides
|
van Kester, Marloes S. |
|
2011 |
|
3 |
p. 273-280 8 p. |
article |
92 |
MiR-Score: A novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma
|
Kirschner, Michaela B. |
|
2015 |
|
3 |
p. 715-726 12 p. |
article |
93 |
Molecular basis for therapy resistance
|
Lønning, Per E. |
|
2010 |
|
3 |
p. 284-300 17 p. |
article |
94 |
Molecular characterization of apocrine carcinoma of the breast: Validation of an apocrine protein signature in a well-defined cohort
|
Celis, Julio E. |
|
2009 |
|
3 |
p. 220-237 18 p. |
article |
95 |
Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts
|
Topp, Monique D. |
|
2014 |
|
3 |
p. 656-668 13 p. |
article |
96 |
Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition
|
Young, Natalie R. |
|
2013 |
|
3 |
p. 359-368 10 p. |
article |
97 |
Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancer
|
Smerage, Jeffrey B. |
|
2013 |
|
3 |
p. 680-692 13 p. |
article |
98 |
Multi-level gene expression signatures, but not binary, outperform Ki67 for the long term prognostication of breast cancer patients
|
Tobin, Nicholas P. |
|
2014 |
|
3 |
p. 741-752 12 p. |
article |
99 |
Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress
|
Maya-Mendoza, Apolinar |
|
2015 |
|
3 |
p. 601-616 16 p. |
article |
100 |
MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: A molecular portrait of stage 4S
|
Bénard, Jean |
|
2008 |
|
3 |
p. 261-271 11 p. |
article |
101 |
Neurotensin signaling induces intracellular alkalinization and interleukin-8 expression in human pancreatic cancer cells
|
Olszewski, Ulrike |
|
2009 |
|
3 |
p. 204-213 10 p. |
article |
102 |
New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family
|
Emami, Nashmil |
|
2007 |
|
3 |
p. 269-287 19 p. |
article |
103 |
New members of the Editorial Board
|
|
|
2011 |
|
3 |
p. 215-216 2 p. |
article |
104 |
News from ECCO
|
Fricker, Janet |
|
2007 |
|
3 |
p. 258-262 5 p. |
article |
105 |
NFκB and STAT3 synergistically activate the expression of FAT10, a gene counteracting the tumor suppressor p53
|
Choi, Yongwook |
|
2014 |
|
3 |
p. 642-655 14 p. |
article |
106 |
Non-invasive detection of genome-wide somatic copy number alterations by liquid biopsies
|
Heitzer, Ellen |
|
2016 |
|
3 |
p. 494-502 9 p. |
article |
107 |
N-terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy
|
Martin, Sarah K. |
|
2015 |
|
3 |
p. 628-639 12 p. |
article |
108 |
Obesity induced rapid melanoma progression is reversed by orlistat treatment and dietary intervention: Role of adipokines
|
Malvi, Parmanand |
|
2015 |
|
3 |
p. 689-703 15 p. |
article |
109 |
On the molecular biology of breast cancer
|
Børresen-Dale, Anne-Lise |
|
2010 |
|
3 |
p. 171-173 3 p. |
article |
110 |
Optimize radiochemotherapy in pancreatic cancer: PARP inhibitors a new therapeutic opportunity
|
Porcelli, Letizia |
|
2013 |
|
3 |
p. 308-322 15 p. |
article |
111 |
Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours
|
Ferreira, José Alexandre |
|
2013 |
|
3 |
p. 719-731 13 p. |
article |
112 |
Patient advocacy groups: Empowering patients in their fight against cancer
|
Fricker, Janet |
|
2007 |
|
3 |
p. 252-254 3 p. |
article |
113 |
Patient-derived xenografts recapitulate molecular features of human uveal melanomas
|
Laurent, Cécile |
|
2013 |
|
3 |
p. 625-636 12 p. |
article |
114 |
Patient organisations aim for greater collaboration
|
Wilkinson, Emma |
|
2008 |
|
3 |
p. 200-202 3 p. |
article |
115 |
Personal Profiles
|
|
|
2007 |
|
3 |
p. 237-243 7 p. |
article |
116 |
Personal Profiles
|
|
|
2009 |
|
3 |
p. 187- 1 p. |
article |
117 |
Photoimmunotherapy: Comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor
|
Sato, Kazuhide |
|
2014 |
|
3 |
p. 620-632 13 p. |
article |
118 |
Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model
|
Hafeez, Bilal Bin |
|
2013 |
|
3 |
p. 428-439 12 p. |
article |
119 |
Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530
|
Green, Tim P. |
|
2009 |
|
3 |
p. 248-261 14 p. |
article |
120 |
Preclinical study on combined chemo- and nonviral gene therapy for sensitization of melanoma using a human TNF-alpha expressing MIDGE DNA vector
|
Kobelt, Dennis |
|
2014 |
|
3 |
p. 609-619 11 p. |
article |
121 |
Prediction of clinical outcome in glioblastoma using a biologically relevant nine-microRNA signature
|
Hayes, Josie |
|
2015 |
|
3 |
p. 704-714 11 p. |
article |
122 |
Prevention of BMS-777607-induced polyploidy/senescence by mTOR inhibitor AZD8055 sensitizes breast cancer cells to cytotoxic chemotherapeutics
|
Sharma, Sharad |
|
2014 |
|
3 |
p. 469-482 14 p. |
article |
123 |
Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): Favorable activity of targeting EGFR- ErbB2 signaling with lapatinib
|
Singh, Anjali |
|
2013 |
|
3 |
p. 497-512 16 p. |
article |
124 |
Prognostic value of peripheral blood double detection of CK19 and MUC1 mRNA positive cells detected by RT-quantitative PCR in 94 breast cancer patients with a follow up of 9 years
|
Pierga, J.-Y. |
|
2007 |
|
3 |
p. 267-268 2 p. |
article |
125 |
Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients
|
Draht, Muriel X.G. |
|
2014 |
|
3 |
p. 679-688 10 p. |
article |
126 |
Promoter methylation of the SALL2 tumor suppressor gene in ovarian cancers
|
Sung, Chang K. |
|
2013 |
|
3 |
p. 419-427 9 p. |
article |
127 |
Protein arginine methyltransferase 5 is a key regulator of the MYCN oncoprotein in neuroblastoma cells
|
Park, Ji Hyun |
|
2015 |
|
3 |
p. 617-627 11 p. |
article |
128 |
Protein inhibitor of activated STAT3 expression in lung cancer
|
Kluge, Amy |
|
2011 |
|
3 |
p. 256-264 9 p. |
article |
129 |
Protein Shakes – the future is not here yet for proteomic–based companion diagnostics, but it's coming
|
Dumiak, Michael |
|
2011 |
|
3 |
p. 220-223 4 p. |
article |
130 |
p70S6 kinase mediates breast cancer cell survival in response to surgical wound fluid stimulation
|
Segatto, Ilenia |
|
2014 |
|
3 |
p. 766-780 15 p. |
article |
131 |
Quantifying initial cellular events of mouse radiation lymphomagenesis and its tumor prevention in vivo by positron emission tomography and magnetic resonance imaging
|
Hasegawa, Sumitaka |
|
2015 |
|
3 |
p. 740-748 9 p. |
article |
132 |
Regulation of the localisation and function of the oncogene LYRIC/AEG-1 by ubiquitination at K486 and K491
|
Luxton, Hayley J. |
|
2014 |
|
3 |
p. 633-641 9 p. |
article |
133 |
Response to “Is metastasis predetermined?”
|
Tarin, David |
|
2007 |
|
3 |
p. 265-266 2 p. |
article |
134 |
Reversal of gastrointestinal carcinoma-induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL-12
|
Malvicini, Mariana |
|
2011 |
|
3 |
p. 242-255 14 p. |
article |
135 |
Screening for circulating nucleic acids and caspase activity in the peripheral blood as potential diagnostic tools in lung cancer
|
Roth, Carina |
|
2011 |
|
3 |
p. 281-291 11 p. |
article |
136 |
Sequential Cdk1 and Plk1 phosphorylation of caspase-8 triggers apoptotic cell death during mitosis
|
Matthess, Yves |
|
2014 |
|
3 |
p. 596-608 13 p. |
article |
137 |
Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response
|
Chen, Yu-Li |
|
2012 |
|
3 |
p. 360-369 10 p. |
article |
138 |
Shaping science policy in Europe
|
Celis, Julio E. |
|
2014 |
|
3 |
p. 447-457 11 p. |
article |
139 |
Short telomere length in peripheral blood leukocyte predicts poor prognosis and indicates an immunosuppressive phenotype in gastric cancer patients
|
Qu, Falin |
|
2015 |
|
3 |
p. 727-739 13 p. |
article |
140 |
Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells
|
Carrascal, Mylène A. |
|
2014 |
|
3 |
p. 753-765 13 p. |
article |
141 |
Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer
|
Ma, Xiaoli |
|
2014 |
|
3 |
p. 555-564 10 p. |
article |
142 |
Structural and genic characterization of stable genomic regions in breast cancer: Relevance to chemotherapy
|
Park, Nicole I. |
|
2012 |
|
3 |
p. 347-359 13 p. |
article |
143 |
Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon-β via their tumor-tropic effect in cellular and xenograft mouse models
|
Yi, Bo-Rim |
|
2013 |
|
3 |
p. 543-554 12 p. |
article |
144 |
Suppressor of cytokine signaling 2 (SOCS2) associates with FLT3 and negatively regulates downstream signaling
|
Kazi, Julhash U. |
|
2013 |
|
3 |
p. 693-703 11 p. |
article |
145 |
Targeted tumor therapy by epidermal growth factor appended toxin and purified saponin: An evaluation of toxicity and therapeutic potential in syngeneic tumor bearing mice
|
Thakur, Mayank |
|
2013 |
|
3 |
p. 475-483 9 p. |
article |
146 |
Targeting HER2-positive cancer cells with receptor-redirected anthrax protective antigen
|
McCluskey, Andrew J. |
|
2013 |
|
3 |
p. 440-451 12 p. |
article |
147 |
The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr–Abl activity in chronic myeloid leukemia
|
Hantschel, Oliver |
|
2008 |
|
3 |
p. 272-281 10 p. |
article |
148 |
The cost of hope: Doctors weigh the benefits of new drugs against sky-high costs
|
Loewenberg, Samuel |
|
2010 |
|
3 |
p. 301-303 3 p. |
article |
149 |
The epigenetics of breast cancer
|
Jovanovic, Jovana |
|
2010 |
|
3 |
p. 242-254 13 p. |
article |
150 |
The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells
|
Sahlberg, Kristine Kleivi |
|
2013 |
|
3 |
p. 392-401 10 p. |
article |
151 |
The High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression
|
Mussnich, Paula |
|
2013 |
|
3 |
p. 531-542 12 p. |
article |
152 |
The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma
|
Montes de Oca, Rocío |
|
2015 |
|
3 |
p. 657-674 18 p. |
article |
153 |
The interaction of PKN3 with RhoC promotes malignant growth
|
Unsal-Kacmaz, Keziban |
|
2012 |
|
3 |
p. 284-298 15 p. |
article |
154 |
The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer
|
Kashyap, Vasundhra |
|
2013 |
|
3 |
p. 555-566 12 p. |
article |
155 |
The MINDACT trial: The first prospective clinical validation of a genomic tool
|
Cardoso, Fatima |
|
2007 |
|
3 |
p. 246-251 6 p. |
article |
156 |
The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL
|
Wang, Peng |
|
2013 |
|
3 |
p. 334-345 12 p. |
article |
157 |
The state of academic cancer surgery in the UK
|
Eckhouse, S. |
|
2008 |
|
3 |
p. 206-212 7 p. |
article |
158 |
The toxin component of targeted anti-tumor toxins determines their efficacy increase by saponins
|
Weng, Alexander |
|
2012 |
|
3 |
p. 323-332 10 p. |
article |
159 |
The tyrosine phosphatase SHP2 is required for cell transformation by the receptor tyrosine kinase mutants FIP1L1-PDGFRα and PDGFRα D842V
|
Noël, Laura A. |
|
2014 |
|
3 |
p. 728-740 13 p. |
article |
160 |
TIMP-1 expression in human colorectal cancer is associated with TGF-B1, LOXL2, INHBA1, TNF-AIP6 and TIMP-2 transcript profiles
|
Offenberg, Hanne |
|
2008 |
|
3 |
p. 233-240 8 p. |
article |
161 |
TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers
|
Győrffy, Balázs |
|
2014 |
|
3 |
p. 508-519 12 p. |
article |
162 |
Tracing the tumor lineage
|
Navin, Nicholas E. |
|
2010 |
|
3 |
p. 267-283 17 p. |
article |
163 |
Triple-negative breast cancer: Present challenges and new perspectives
|
Podo, Franca |
|
2010 |
|
3 |
p. 209-229 21 p. |
article |
164 |
UK’s adopts systematic approach to personalised cancer medicine
|
Fricker, Janet |
|
2011 |
|
3 |
p. 217-219 3 p. |
article |
165 |
Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer
|
Abdel-Fatah, Tarek M.A. |
|
2015 |
|
3 |
p. 569-585 17 p. |
article |
166 |
Use of high density antibody arrays to validate and discover cancer serum biomarkers
|
Loch, Christian M. |
|
2007 |
|
3 |
p. 313-320 8 p. |
article |
167 |
Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system
|
Stricker, Thomas P. |
|
2014 |
|
3 |
p. 669-678 10 p. |
article |
168 |
Vascular endothelial growth factor restores delayed tumor progression in tumors depleted of macrophages
|
Lin, Elaine Y. |
|
2007 |
|
3 |
p. 288-302 15 p. |
article |
169 |
VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancer
|
Gambaro, Karen |
|
2013 |
|
3 |
p. 513-530 18 p. |
article |
170 |
Volume contents
|
|
|
2007 |
|
3 |
p. 359-362 4 p. |
article |
171 |
Whole transcriptome analysis of the ERα synthetic fragment P295-T311 (ERα17p) identifies specific ERα-isoform (ERα, ERα36)-dependent and -independent actions in breast cancer cells
|
Notas, George |
|
2013 |
|
3 |
p. 595-610 16 p. |
article |
172 |
Will the Innovative Medicines Initiative really deliver innovative medicines?
|
Wilkinson, Emma |
|
2008 |
|
3 |
p. 203-205 3 p. |
article |